Heart Test Laboratories (HSCS) Competitors $2.84 -0.07 (-2.41%) Closing price 03/27/2025 03:59 PM EasternExtended Trading$2.88 +0.04 (+1.55%) As of 03/27/2025 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock HSCS vs. PETV, LYRA, BTCY, SSKN, IINN, NURO, WOK, PAVM, STRR, and BSGMShould you be buying Heart Test Laboratories stock or one of its competitors? The main competitors of Heart Test Laboratories include PetVivo (PETV), Lyra Therapeutics (LYRA), Biotricity (BTCY), STRATA Skin Sciences (SSKN), Inspira Technologies Oxy B.H.N. (IINN), NeuroMetrix (NURO), WORK Medical Technology Group LTD Ordinary Shares (WOK), PAVmed (PAVM), Star Equity (STRR), and BioSig Technologies (BSGM). These companies are all part of the "medical equipment" industry. Heart Test Laboratories vs. PetVivo Lyra Therapeutics Biotricity STRATA Skin Sciences Inspira Technologies Oxy B.H.N. NeuroMetrix WORK Medical Technology Group LTD Ordinary Shares PAVmed Star Equity BioSig Technologies Heart Test Laboratories (NASDAQ:HSCS) and PetVivo (NASDAQ:PETV) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, community ranking, analyst recommendations, valuation, institutional ownership, media sentiment, dividends and profitability. Which has better earnings and valuation, HSCS or PETV? Heart Test Laboratories has higher earnings, but lower revenue than PetVivo. PetVivo is trading at a lower price-to-earnings ratio than Heart Test Laboratories, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHeart Test Laboratories$14.70K208.85-$6.61M-$7.48-0.38PetVivo$1.05M12.16-$10.95M-$0.45-1.20 Does the MarketBeat Community favor HSCS or PETV? Heart Test Laboratories received 6 more outperform votes than PetVivo when rated by MarketBeat users. CompanyUnderperformOutperformHeart Test LaboratoriesOutperform Votes685.71% Underperform Votes114.29%PetVivoN/AN/A Which has more volatility & risk, HSCS or PETV? Heart Test Laboratories has a beta of 2.77, meaning that its stock price is 177% more volatile than the S&P 500. Comparatively, PetVivo has a beta of 2.38, meaning that its stock price is 138% more volatile than the S&P 500. Do analysts recommend HSCS or PETV? Heart Test Laboratories presently has a consensus price target of $13.00, suggesting a potential upside of 357.75%. Given Heart Test Laboratories' stronger consensus rating and higher possible upside, equities analysts clearly believe Heart Test Laboratories is more favorable than PetVivo.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Heart Test Laboratories 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00PetVivo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is HSCS or PETV more profitable? Heart Test Laboratories has a net margin of 0.00% compared to PetVivo's net margin of -902.82%. Heart Test Laboratories' return on equity of -117.76% beat PetVivo's return on equity.Company Net Margins Return on Equity Return on Assets Heart Test LaboratoriesN/A -117.76% -84.09% PetVivo -902.82%-4,813.07%-281.78% Does the media prefer HSCS or PETV? In the previous week, Heart Test Laboratories had 4 more articles in the media than PetVivo. MarketBeat recorded 5 mentions for Heart Test Laboratories and 1 mentions for PetVivo. Heart Test Laboratories' average media sentiment score of 0.81 beat PetVivo's score of 0.00 indicating that Heart Test Laboratories is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Heart Test Laboratories 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive PetVivo 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do institutionals and insiders hold more shares of HSCS or PETV? 17.2% of Heart Test Laboratories shares are held by institutional investors. Comparatively, 24.5% of PetVivo shares are held by institutional investors. 1.8% of Heart Test Laboratories shares are held by insiders. Comparatively, 10.8% of PetVivo shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. SummaryHeart Test Laboratories beats PetVivo on 13 of the 17 factors compared between the two stocks. Remove Ads Get Heart Test Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for HSCS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HSCS vs. The Competition Export to ExcelMetricHeart Test LaboratoriesSurgical appliances & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.07M$9.01B$5.65B$8.06BDividend YieldN/A1.41%4.57%4.01%P/E Ratio-0.3617.5823.1619.03Price / Sales208.8565.74386.8193.17Price / CashN/A19.6738.1634.64Price / Book0.255.536.914.33Net Income-$6.61M$284.66M$3.20B$247.06M7 Day Performance-2.41%-0.55%-2.30%-0.37%1 Month Performance-20.22%-3.45%2.86%-3.85%1 Year Performance-75.71%-19.30%10.51%1.27% Heart Test Laboratories Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HSCSHeart Test Laboratories2.8231 of 5 stars$2.84-2.4%$13.00+357.7%-75.7%$3.07M$14,700.00-0.3610PETVPetVivoN/A$0.53+1.9%N/A-50.5%$12.49M$1.05M-1.1820News CoverageGap DownLYRALyra Therapeutics2.6821 of 5 stars$0.16-6.8%$1.25+666.4%-97.7%$11.53M$1.53M-0.1150Short Interest ↑BTCYBiotricityN/A$0.44-7.7%N/A-72.2%$10.90M$12.06M-0.4140Gap DownSSKNSTRATA Skin Sciences2.9063 of 5 stars$2.57-4.1%$6.00+133.5%-40.7%$10.72M$32.68M-0.97120Short Interest ↑News CoverageGap DownIINNInspira Technologies Oxy B.H.N.0.8381 of 5 stars$0.77-0.6%N/A-59.5%$9.72MN/A0.0020Gap DownNURONeuroMetrix0.9271 of 5 stars$4.55+0.8%N/A+8.2%$9.33M$3.77M-0.9920Analyst ForecastShort Interest ↓News CoverageWOKWORK Medical Technology Group LTD Ordinary SharesN/A$0.62-3.1%N/AN/A$9.05M$11.51M0.00226Gap DownPAVMPAVmed4.4066 of 5 stars$0.80-1.2%$19.00+2,275.0%-71.9%$8.86M$4.03M-0.1890Short Interest ↓News CoverageSTRRStar Equity1.2674 of 5 stars$2.67+10.3%N/A-41.2%$8.59M$50.38M-1.04460Analyst RevisionHigh Trading VolumeBSGMBioSig Technologies2.0734 of 5 stars$0.49-9.4%$2.75+456.9%-13.1%$8.51M$39,000.000.0050News CoverageGap DownHigh Trading Volume Remove Ads Related Companies and Tools Related Companies PetVivo Competitors Lyra Therapeutics Competitors Biotricity Competitors STRATA Skin Sciences Competitors Inspira Technologies Oxy B.H.N. Competitors NeuroMetrix Competitors WORK Medical Technology Group LTD Ordinary Shares Competitors PAVmed Competitors Star Equity Competitors BioSig Technologies Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HSCS) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredA $6.9 Trillion Cash Tsunami Is Coming – Move Your Money NOWExpert: "Prepare For the Mother of All Melt-Ups" In the wake of Wall Street volatility, stock-picking legen...Stansberry Research | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Heart Test Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Heart Test Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HSCS Stock Free HSCS Stock Alerts